Editors-in-Chief
Xiangdong Wang MD, PhD, Professor and Director of Shanghai Institute of Clinical Bioinformatics and Clinical Science Institute, Fudan University Zhongshan Hospital, Shanghai, China 

Advisory Board
Dan Peer PhD, Professor and Head, Laboratory of NanoMedicine, Dep. Of Cell Research & Immunology, Director, FTA:Nanomedicines for Personalized Theranostics, Tel Aviv University Tel-Aviv, Israel

Ming Qian WEI, PhD, Professor of Microbiology, Director, Division for Molecular and Gene Therapies, Co-director, Griffith University Infectious Disease Group, Griffith Health Institue, School of Medical Science, Griffith University, Gold Coast campus, Southport, Adjunct Professor, University of Queensland, Brisbane, Australia

John E. J. Rasko AO, Professor, Sydney Medical School, University of Sydney , Head, Gene and Stem Cell Therapy Program, Centenary Institute, Head of Department, Cell & Molecular Therapies, Royal Prince Alfred Hospital, Australia

Elena Lopez Villar, PhD, Spanish National Cancer Research Centre (CNIO), Hospital Infantil Universitario Niño Jesùs, Onco-hematology for Children Department., Av. Menéndez Pelayo, Madrid, Spain

David Pozo Perez, PhD, Dept. Medical Biochemistry, Molecular Biology and Immunology, The University of Seville Medical School, Seville, Spain

Michael N. Liebman, PhD, President/Managing Director, Strategic Medicine, Inc, USA

Satya Prakash, PhD, Professor, Biomedical Engineering, Professor, Artificial Cells and Organs Research Center, Professor, Physiology and Experimental Medicine, Director and Co-Founder, Micropharma, Faculty of Medicine, McGill University, Montreal, Quebec, Canada

Kwang-Hyun Cho, Ph.D. Professor and Head of Department of Bio and Brain Engineering, Korea Advanced Institute of Science and Technology (KAIST), Daejeon, Republic of Korea

Jan Pruszak, PhD, Principal Investigator, Emmy Noether-Group for Stem Cell Biology, Institute of Anatomy and Cell Biology, University of Freiburg, Head, Freiburg iPS Core Facility, Institute for Transfusion Medicine and Gene Therapy, Hugstetter Str. 55, 79106 Freiburg, Germany

Elena Pirogova PhD, Senior Lecturer, Program Director, Biomedical Engineering Undergraduate, School of Electrical and Computer Engineering, Health Innovations Research Institute, RMIT University City Campus, Melbourne VIC, Australia

Fang Liu MD PhD, Professor, Department of Psychiatry, Senior Scientist, Centre for Addiction and Mental Health, University of Toronto, Canada

Jianjie Ma, Ph.D. Karl P. Klassen Chair in Thoracic Surgery, Director, Division of Surgical and Biomedical Sciences, Department of Surgery, Investigator, Davis Heart & Lung Research Institute, The Ohio State University Medical Center, Columbus, USA

Qihong Huang, M.D., PhD, Associate Professor, Tumor Microenvironment and Metastasis Program, The Wistar Institute, Philadelphia, USA

Deirdre R. Coombe, PhD, Professor, School of Biomedical Sciences, Curtin Health Innovation Research Institute, Faculty of Health Sciences, Curtin University, Australia

Shimon Slavin, MD, Professor of Medicine, Scientific & Medical Director, Biotherapy International, Weizmann Center, Tel Aviv, Israel

Kenneth Howard, PhD, Professor, Interdisciplinary Nanoscience Center, INANO-MBG, Aarhus University, Denmark

Marek Malecki, MD PhD, President, Genetic and Biomolecular Engineering, PBMEF, San Francisco, CA, USA

Andrew D. Badley, M.D. Professor of Infectious Diseases and Molecular Medicine, Mayo Clinic, USA

Ann M. Simpson. PhD, Head, School of Medical & Molecular Biosciences, Professor of Biochemistry, Co-Director Centre for Health Technologies, University of Technology, Sydney, Australia